Cantex Pharmaceuticals

United States
Fort Smith, Arkansas, United States
954-315-3660 ★

Company profile

Cantex Pharmaceuticals company profile

Cantex Pharmaceuticals is a biotechnology company engaged in harnessing known therapies to develop novel and safer cancer treatments. Cantex is currently conducting two unique development programs with modified versions of two separate known chemical entities each of which addresses major unmet medical needs representing high-value market opportunities:

Business identity

Contact email
[email protected]
Phone number
954-315-3660
Operating status
Active
Company type
For Profit
Employee range
00001-00010 employees
Revenue range
$1K+
Founded
2002-01-01

Headquarters

Headquarters
Fort Smith, Arkansas, United States
Postal code
33326
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
6
Total equity funding
$27.4M
Last funding
Debt Financing / $3.3M / 2014-04-22
Last equity funding
Series C / $4.4M
Investors
5
Lead investors
4
Founders
1
Articles
15

Founders and investors

Founders

Stephen Marcus

Lead investors

CHL Medical PartnersDomain AssociatesResearch Corporation TechnologiesVenture Academy

Investors

CHL Medical PartnersDomain AssociatesResearch Corporation TechnologiesThe Aurora FundsVenture Academy

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.